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A B S T R A C T
Background: While optimal cardiovascular risk factor (CRF) profile is associated with lower mortality, morbidity,
and healthcare expenditures among individuals with atherosclerotic cardiovascular disease (ASCVD), less is
known regarding its impact on financial hardship from medical bills. Therefore, we assessed whether an optimal
CRF profile is associated with a lower burden of financial hardship from medical bills and a reduction in cost-
related barriers to health.
Methods: We used a nationally representative sample of adults between 18 and 64 years from the National Health
Interview Survey between 2013 and 2017. We assessed ASCVD status and the number of risk factors to categorize
the study population into 4 mutually exclusive categories: ASCVD (irrespective of CRF profile) and non-ASCVD
with poor, average, and optimal CRF profile. Adjusted logistic regression model was used to determine the as-
sociation of ASCVD/CRF profile with financial hardship from medical bills and cost-related barriers to health
(cost-related medication non-adherence (CRN), foregone/delayed care, and high financial distress).
Results: We included 119,388 non-elderly adults, representing 189 million individuals annually across the United
States. Non-ASCVD/optimal CRF profile individuals had a lower prevalence of financial hardship and an inability
paying medical bills when compared with individuals with ASCVD (24% vs 45% and 6% vs 19%, respectively).
Among individuals without ASCVD and an optimal CRF profile, the prevalence of each cost-related barrier to
health was <50% compared with individuals with ASCVD. Poor/low income and uninsured individuals within
non-ASCVD/average CRF profile strata had a lower prevalence of financial hardship and an inability paying
medical bills when compared with middle/high income and insured individuals with ASCVD. Non-ASCVD in-
dividuals with optimal CRF profile had the lowest odds of all barriers to health.
Conclusion: Optimal CRF profile is associated with a lower prevalence of financial hardship from medical bills and
cost-related barriers to health despite lower income and lack of insurance.
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1. Introduction
Atherosclerotic cardiovascular disease (ASCVD) remains a leading
cause of morbidity and mortality in the United States and around the
world. Patients with ASCVD endure significant financial burden from
direct and indirect medical costs, life-years lost, and diminished quality
of life related to their condition [1]. In 2010, the American Heart Asso-
ciation launched the 2020 Strategic Impact Goals, which defined the
concept of ideal cardiovascular health (CVH), including adequate man-
agement of hypertension, diabetes, and total cholesterol, smoking
abstinence, maintaining a healthy weight and diet, and engaging in
physical activity [2]. It is now well established that an optimal cardio-
vascular risk factor (CRF) profile, as a measure of CVH, is associated with
favorable cardiovascular outcomes, including lower mortality and
morbidity rates [3–6], as well as decreased healthcare expenditures and
cardiovascular costs later in life, regardless of ASCVD status [7–9]. To
date, however, less is knownwhether an optimal CRF profile is associated
with lower financial hardship among affected individuals. Therefore, in
this study we sought to describe financial hardship from medical bills
across the spectrum of varying CRF profiles and an ASCVD status from a
nationally representative sample of adults in the United States (US).
Additionally, we analyzed cost-related consequences and barriers
affecting individuals’ health, such as cost-related medication
non-adherence (CRN), foregone/delayed care, and high financial
distress.
2. Materials & methods
2.1. Study design
We utilized pooled, cross-sectional data from the National Health
Interview Survey (NHIS) between 2013 and 2017. The NHIS is a National
Center for Health Statistics/Center for Disease Control and Prevention
database constructed from annual surveys, which incorporates complex,
multi-stage sampling to provide estimates on the noninstitutionalized US
population. This study was based on the Sample Adult Core files, which
were supplemented with demographic and socioeconomic characteris-
tics, health status, healthcare services, and health-related behaviors from
the US adult population. Since NHIS data is publicly available as de-
identified data, this study was exempt from the Institutional Review
Board Committee. We limited our study to focus on non-elderly (18–64
years of age) adults with ASCVD status and CRF profile information to
capture the population without universal public insurance, which may
provide enhanced protection from the financial-related outcomes of
interest.
2.2. Study variable
2.2.1. ASCVD and CRF profiles
Individuals who self-reported having coronary artery disease
(answered “yes” to any of the following 3 questions: “Have you ever been
told by a doctor or other health professional that you had … coronary heart
disease? or … angina, also called angina pectoris? or … a heart attack (also
called myocardial infarction)?”) and/or stroke disease (answered “yes” to
the following question: “Have you ever been told by a doctor or other health
professional that you had a stroke?”), were established as having ASCVD.
CRF profile was ascertained based on the presence of 1 or more of the
following self-reported clinical characteristics: diagnosis of hypertension,
diabetes mellitus, or high cholesterol, current smoker, obesity (body
mass index 30 kg/m2), or insufficient physical activity (75 min/week
of vigorous-intensity activity or 150 min/week moderate-intensity ac-
tivity or combination) [2]. The sum of the risk factors an individual
accrued was used to determine the CRF profile: “poor/unfavorable” (4
CRFs) and “favorable” (<4 CRFs) (“average” [2–3 CRFs] or “optimal”
[0–1 CRF]).
2.3. Outcome variables
2.3.1. Financial hardship from medical bills
Individuals were classified as having “financial hardship from medi-
cal bills” if they answered “yes” to either of the following questions: “In
the past 12 months did you/anyone in your family have problems paying or
were unable to pay any medical bills? Include bills for doctors, dentists, hos-
pitals, therapists, medication, equipment, nursing home or home care” and
“Do you/anyone in your family currently have any medical bills that are being
paid off over time? This could include medical bills being paid off with a credit
card, through personal loans, or bill paying arrangements with hospitals or
other providers. The bills can be from earlier years as well as this year.” In-
dividuals who answered “yes” to having any problems paying bills were
then asked a follow-up question: “Do you/Does anyone in your family
currently have any medical bills that you are unable to pay at all?” Those
who answered “yes” to the follow-up question were classified as “unable
to pay medical bills at all”, a proxy of the most vulnerable individuals.
2.3.2. Cost-related barriers to health
Individualswho reportedmoney-savingbehaviors in thepast12months
asdescribed inTable1,weredefinedtohaveCRN. Individualswhoreported
to have delayed care or have not sought out care because they could not
afford it or because theywereworried about the costs in the past 12months
were defined to have foregone/delayed care (Table 1) [10]. Financial
distresswas derived from6 questions addressing “worry” regarding several
financial matters in the past 12 months as mentioned in Table 1. All ques-
tionswereansweredona4-point scale, ranging from0(notworriedatall) to
4 (veryworried).Anaggregate scorewas created, ranging from6 to24,with
a higher score translating into higher stress [11], which was divided into
quartiles. Individuals among thehighest quartile (i.e. thosewith thehighest
scores) were then classified as having high financial distress.
2.4. Covariates
Other covariates included in this study were age (18–39 and 40–64
years), sex, family size (0, 1, and 2), family income (middle/high
Table 1
Itemized questions for Cost-related Barriers to Health.
Cost-related Medication Non-adherence
During the past 12 months, were any of the following true for you? (Yes/No)
1 You skipped medication doses to save money
2 You took less medicine to save money
3 You delayed filling a prescription to save money
Forgone/Delayed Care
During the past 12 months, were any of the following true for you? (Yes/No)
1 Has medical care been delayed for you because of worry about the cost? (Do not
include dental care)
2 Was there any time when you needed medical care, but did not get it because you
couldn’t afford it?
3 Was there any time when you needed any of the following, but didn’t get it because
you couldn’t afford it?
a Prescription medicines
b. Mental healthcare or counseling
c. Dental care
d. Eyeglasses
e To see a specialist
f. Follow-up care
High Financial Distress
How worried (very worried, moderately worried, not too worried, not worried at all)
are you right now about
1 Not having enough money for retirement?
2 Not being able to pay medical costs of a serious illness or accident?
3 Not being able to maintain the standard of living you enjoy?
4 Not being able to pay medical costs for normal healthcare?
5 Not having enough to pay your normal monthly bills?
6 Not being able to pay your rent, mortgage, or other housing costs?
G.R. Grandhi et al. American Journal of Preventive Cardiology 2 (2020) 100034
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income [200% federal poverty limit] and low/poor-income [<200%
federal poverty limit]), race/ethnicity (non-Hispanic white, non-
Hispanic black, non-Hispanic Asian, and Hispanic), insurance status
(insured and uninsured), education (at least some college education and
less than college education), region (Northeast, Midwest, South, and
West), and number of chronic comorbidities. Chronic comorbidities were
self-reported and included emphysema, chronic obstructive pulmonary
disease, asthma, gastrointestinal ulcer, cancer (any), arthritis (including
arthritis, gout, fibromyalgia, rheumatoid arthritis, and systemic lupus
erythematosus), any kind of liver condition, and “weak/failing” kidneys,
were aggregated and categorized as having 0, 1, or  2.
2.5. Statistical analysis
We utilized data from the Integrated Public Use Microdata Series
(http://www.ipums.org) to correctly calculate variance estimation for
nationally representative results, since 5 years of pooled data were used
for analysis. We divided the study population into 4 mutually exclusive
groups based on the ASCVD status and CRF profile: ASCVD (irrespective
of the CRF profile), non-ASCVD with poor CRF profile, non-ASCVD with
average CRF profile, and non-ASCVD with optimal CRF profile. We
compared the baseline characteristics of the study population using χ2
analysis across the pre-specified ASCVD/CRF profile groups and studied
the prevalence using weighted proportions. We used logistic regression
model adjusted for age, sex, family size, family income, race/ethnicity,
insurance status, education, comorbidities, and region to calculate odds
ratios to determine the association of ASCVD/CRF profile on financial
hardship from medical bills, and cost-related barriers to health (CRN,
foregone/delayed care, and high financial distress). Additionally, we
conducted a sub-analysis among participants with ASCVD stratified by
CRF profile status to ascertain unadjusted and adjusted associations with
financial hardship frommedical bills, an inability to pay bills at all, along
with the aforementioned barriers to health. We performed all statistical
analyses using Stata®, version 15.1 (StataCorp, LP, College Station,
Texas, USA). A two-tailed p-value of <0.05 was considered statistically
significant for all analyses. All analyses were survey-specific and
considered the complex NHIS survey design.
3. Results
Our study population consisted of 119,388 individuals (between18 and
64 years), representing 72% of total cohort surveyed byNHIS from 2013 to
2017. This sample represented 189million non-elderly US adults annually.
Mean age was 41  7.7 years and 49% were men. Overall, 4.6% (95% CI:
4.4%, 4.8%) of the weighted study population had ASCVD. Among those
withoutASCVD,6%hadapoorCRFprofile, 31.8%averageCRFprofile, and
57.6% optimal CRF profile. General characteristics of the study population
are displayed in Table 2. Non-ASCVD/optimal CRF profile individualswere
younger (18–39years old), frommiddle/high income families,witha lower
comorbidity count, and were more likely to have at least some college ed-
ucation when compared to individuals with ASCVD.
3.1. Burden of ASCVD and non-ASCVD/CRF profile on financial hardship
Fig. 1 depicts the prevalence of financial hardship from medical bills
and an inability to pay bills. Nearly half (45.2%) of the individuals with
ASCVD had financial hardship from medical bills and 19% were unable
to pay medical bills at all. In contrast, individuals without ASCVD and an
Table 2
General characteristics of the study population by ASCVD and non-ASCVD/CRF profile status.
Total ASCVD No ASCVD p-value
Poor
CRF Profile
Average
CRF Profile
Optimal
CRF Profile
Sample (N) 119,388 6160 7878 38,768 66,582
Weighted sample, (weighted %) 188,861,117 8,696,486 (4.6) 11,381,648 (6.0) 60,102,341 (31.8) 108,680,642 (57.6)
Age Category, n (weighted %) <0.001
18-39 54,192 (47.6) 684 (12.4) 1061 (13.9) 14,010 (37.9) 38,437 (59.3)
40-64 65,196 (52.4) 5476 (87.6) 6817 (86.1) 24,758 (62.1) 28,145 (40.7)
Sex, n (weighted %) <0.001
Male 55,045 (49.0) 3317 (57.5) 3445 (47.7) 17,661 (49.3) 30,622 (48.3)
Female 64,343 (51.0) 2843 (42.5) 4433 (52.3) 21,107 (50.7) 35,960 (51.7)
Race/Ethnicity, n (weighted %) <0.001
Non-Hispanic White 73,736 (63.4) 3945 (67.1) 4844 (65.8) 23,632 (63.1) 41,315 (62.9)
Non-Hispanic Black 16,316 (12.9) 1118 (16.4) 1583 (17.3) 6207 (14.8) 7408 (11.2)
Non-Hispanic Asian 7219 (6.2) 159 (2.8) 197 (2.8) 1571 (4.5) 5292 (7.7)
Hispanic 20,466 (17.5) 799 (13.7) 1093 (14.1) 6725 (17.5) 11,849 (18.1)
Family Size, n (weighted %) <0.001
1 36,025 (17.0) 2423 (22.9) 2768 (19.6) 10,970 (15.7) 19,864 (17.0)
2 33,903 (28.8) 2095 (38.1) 2682 (37.5) 11,775 (30.6) 17,351 (26.2)
3 49,460 (54.2) 1642 (39.0) 2428 (42.9) 16,023 (53.7) 29,367 (56.8)
Family Income, n (weighted %) <0.001
Middle/High-Income 71,353 (68.6) 2690 (53.8) 4001 (59.8) 21,843 (64.5) 42,819 (73.0)
Poor/Low-Income 41,033 (31.4) 3137 (46.2) 3474 (40.2) 14,561 (35.5) 19,861 (27.0)
Insurance Status, n (weighted %) <0.001
Insured 100,559 (85.5) 5407 (88.2) 6908 (88.3) 31,890 (83.5) 56,354 (86.2)
Uninsured 18,268 (14.5) 731 (11.8) 944 (11.7) 6724 (16.5) 9869 (13.8)
Education, n (weighted %) <0.001
Some College or Higher 76,488 (64.2) 3057 (51.1) 3902 (50.3) 21,988 (56.8) 47,541 (70.8)
HS/GED or Less than HS 42,513 (35.8) 3081 (48.9) 3939 (49.7) 16,613 (43.2) 18,880 (29.2)
Region, n (weighted %) <0.001
Northeast 18,904 (17.4) 907 (15.2) 1154 (15.8) 5943 (16.7) 10,900 (18.1)
Midwest 25,812 (22.4) 1370 (24.4) 1810 (24.1) 8872 (23.7) 13,760 (21.4)
South 42,569 (36.5) 2588 (42.4) 3228 (41.5) 14,602 (38.8) 22,151 (34.3)
West 32,103 (23.7) 1295 (18.0) 1686 (18.6) 9351 (20.7) 19,771 (26.3)
Comorbidities, n (weighted %) <0.001
0 76,882 (66.2) 1880 (32.7) 2886 (38.4) 22,891 (61.0) 49,225 (74.6)
1 29,432 (24.1) 1862 (31.0) 2755 (35.1) 10,878 (27.4) 13,937 (20.6)
2 13,074 (9.7) 2418 (36.3) 2237 (26.5) 4999 (11.6) 3420 (4.8)
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovascular risk factor; HS, high school; GED, general equivalency diploma.
G.R. Grandhi et al. American Journal of Preventive Cardiology 2 (2020) 100034
3
optimal CRF profile had a lower prevalence of financial hardship from
medical bills (24.3%) and an inability paying medical bills (5.8%).
Among ASCVD and non-ASCVD/poor CRF profile individuals, the prev-
alence of being unable to pay medical bills at all was 40% of those with
financial hardship frommedical bills when compared to only 24% among
non-ASCVD/optimal CRF profile individuals. There was a stepwise
decrease in the prevalence of financial hardship measures with
improving CRF among those without ASCVD. These differences persisted
among specific subpopulations as shown in Fig. 2. We found a higher
prevalence of financial hardship and an inability to pay bills at all among
those with lower income and without insurance coverage across ASCVD/
CRF profile strata. Furthermore, individuals with ASCVD among middle/
high income and insured strata, reported a higher prevalence of financial
hardship from medical bills and an inability paying medical bills
compared to non-ASCVD/average CRF profile individuals among poor/
low income and uninsured strata.
Table 3 details the adjusted odds ratios for financial hardship from
medical bills across the spectrum of ASCVD and CRF profile. Individuals
without ASCVD but with a favorable CRF profile (optimal CRF profile:
OR 0.44, 95% CI [0.41, 0.48]; average CRF profile: OR 0.66, 95% CI
[0.61, 0.72]) had significantly lower odds of having financial hardship
from medical bills when compared to individuals with ASCVD; the as-
sociation was similar for being unable to pay medical bills (Table 3). On
the other hand, those without established ASCVD and poor CRF profile
had similar odds of experiencing financial hardship from medical bills
(OR 0.90, 95% CI [0.82, 0.99]) or an inability paying medical bills (OR
0.89, 95% CI [0.78, 1.01]) as that of ASCVD individuals. This trend of
lower odds of financial hardship and an inability to pay medical bills in
association with a more favorable CRF profile persisted among all patient
and disease-related covariates (Tables S1 & S2).
3.2. Burden of ASCVD and non-ASCVD/CRF profile on cost-related
barriers to health
Overall, all cost-related barriers to health measures were most prev-
alent among individuals with ASCVD followed by non-ASCVD in-
dividuals with poor CRF profile (Fig. 3). These differences persisted
among specific subpopulations (Fig. 4), with a higher prevalence among
those with lower income and without insurance coverage. After ac-
counting for demographic and social risk factors, those without ASCVD
and optimal CRF profile individuals had the lowest odds of having CRN
(OR 0.42, 95% CI [0.38, 0.48]), foregone/delayed care (OR 0.41 95% CI
[0.37, 0.45]), and high financial distress (OR 0.52, 95% CI [0.47, 0.58]),
when compared to individuals with ASCVD. Conversely, those without
ASCVD and poor CRF had similar odds of experiencing all cost-related
barriers to health when compared to individuals with ASCVD (Table 4).
3.3. Burden of CRF profile within ASCVD on financial hardship and cost-
related barriers to health
In a sub-analysis among those with ASCVD, we noticed a stepwise
decrease in the prevalence of all measures of financial hardship and cost-
related barriers to health with improving CRF profile. Notably, the
prevalence of being unable to pay medical bills at all and CRN were 50%
lower among individuals with ASCVD and optimal CRF profile when
compared with individuals with ASCVD and poor CRF profile (unable to
pay medical bills at all: 11.5% vs 23.4%; CRN: 14.8% vs 27.3%).
Figures S1 & S2 illustrate the prevalence the outcomes by ASCVD and
CRF profile status. These differences persisted after accounting for de-
mographic and socioeconomic determinants of health (Table S3).
4. Discussion
In a nationally representative sample of US non-elderly adults, we
demonstrated that a favorable CRF profile was associated with lower
financial hardship frommedical bills along with a reduction in previously
described barriers to health including CRN, foregone/delayed care, and
high financial distress. Notably, we found that these results persisted
among all family income and insurance strata. Finally, our results showed
that an optimal CRF profile was inversely associated with financial
hardship from medical bills and an inability to pay medical bills at all
despite a lower income level and lack of insurance coverage.
In recent years with rising healthcare costs, financial burden incurred
by patients and their families from medical bills has drawn significant
national attention. It is nowwell established that individuals with ASCVD
face a particularly high healthcare-related financial burden [12,13], with
1 in 10 families that have a member with ASCVD spending more than
one-third of their income on health-related expenses [13]. These ex-
penses can represent major financial challenges to patients, regardless of
their insurance status, and can lead to a reduction in overall quality of
health and psychological well-being along with other cost-related con-
sequences and tradeoffs such as high financial distress, medication
non-adherence, and foregone/delayed medical care [14,15]. The burden
of financial hardship among individuals with ASCVD is worsened in the
presence of other comorbid conditions such as diabetes mellitus [16,29].
Established risk factors of cardiovascular disease –many of which can
be effectively modified, treated, or controlled – are important drivers of
death and disability. Due to their significance and overall burden, the
AHA’s 2020 Strategic Impact Goals emphasized the importance of opti-
mizing these risk factors as part of a national goal, to reduce CVD
morbidity, mortality, and economic burden. In recent years, multiple
reports have attempted to estimate the potential economic impact of a
favorable CRF profile. Notably, Willis et al. studied the relationship be-
tween cardiovascular status, ideal cardiovascular metrics and healthcare
utilization in middle-aged individuals, and later-life healthcare costs [8].
They found that overall healthcare expenditures were significantly lower
among those with a favorable CV health status. Similarly, Sullivan et al.
demonstrated that individuals without cardiometabolic risk factor clus-
ters, on average, spent $5477 less on healthcare when compared with
those with cardiometabolic risk factor clusters [17]. In a nationally
representative US adult population, Valero-Elizondo et al. demonstrated
lower out-of-pocket costs among those with optimal CRF profile irre-
spective of ASCVD status [7]. Importantly, these benefits were noted
across all socioeconomic groups including those <65 years old.
Fig. 1. Title: Prevalence of Financial Hardship from Medical Bills among Non-
Elderly Adults by ASCVD and Non-ASCVD/CRF Profile Status.
There was a stepwise increase in the prevalence of financial hardship from
medical bills and an inability to pay bills at all with worsening CRF profile.
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovas-
cular risk factor.
G.R. Grandhi et al. American Journal of Preventive Cardiology 2 (2020) 100034
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Our current study adds to the existing literature by documenting
significantly lower financial hardship measures among those with a
favorable CRF status. Findings from our study reiterate the advantages
conferred by an optimal CRF profile beyond lower incidence and mor-
tality from chronic diseases (including diabetes [18], cancer [19,20],
end-stage renal disease [21], and cardiovascular disease [22,23]) and
lower healthcare expenditures and resource utilization [7–9,24]. Our
results further emphasize the importance of preventing and managing
modifiable risk factors, irrespective of underlying CVD status for the
overall health at individual, family, and community levels, in addition to
the economic benefits at the national level.
Our findings also provide insights that secondary prevention among
individuals with ASCVD is equally important as primordial prevention in
protecting one’s family from financial burden and other cost-related
barriers to accessing healthcare services. In our study, we demon-
strated that, among individuals with ASCVD, those with optimal CRF
profile had significantly lower odds of these cost-related consequences
than those with poor CRF profile. These findings underscore the impor-
tance of closely managing cardiovascular risk factors and behaviors
among those with ASCVD to improve the overall cardiovascular health
and financial stability of an individual and his or her family.
The management costs of ASCVD are substantial and constitute a
major source of concern at both the national and individual level. While,
attainment of an optimal CRF profile is associated with an overall relative
Fig. 2. Title: Prevalence of Financial Hardship from Medical Bills by (A), family income (B), insurance status among Non-Elderly Adults by ASCVD and Non-ASCVD/
CRF Profile Status.
Within each CRF profile strata, individuals with lower income and lack of insurance had a higher prevalence of financial hardship from medical bills and an inability to
pay bills at all when compared with individuals with higher income and insurance coverage.
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovascular risk factor.
Table 3
Odds ratios of financial hardship among non-elderly adults by ASCVD and non-
ASCVD/CRF profile status.
ASCVD No ASCVD
Poor CRF
Profile
Average CRF
Profile
Optimal CRF
Profile
OR (95%
CI)
OR (95% CI) OR (95% CI) OR (95% CI)
Financial Hardship from Medical Bills
Model
1
Reference 0.89 (0.81,
0.97)
0.63 (0.59, 0.68) 0.39 (0.36, 0.42)
Model
2
0.90 (0.82,
0.99)
0.66 (0.61, 0.72) 0.44 (0.41, 0.48)
Unable to Pay Medical Bills at All
Model
1
Reference 0.83 (0.74,
0.93)
0.50 (0.45, 0.55) 0.22 (0.20, 0.24)
Model
2
0.89 (0.78,
1.01)
0.56 (0.49, 0.63) 0.30 (0.26, 0.34)
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovas-
cular risk factor; OR, odds ratios; CI, confidence interval.
Model 1: unadjusted model.
Model 2: adjusted for age, sex, race/ethnicity, geographic region, comorbidities,
family size, family income, education, and insurance status.
Fig. 3. Title: Prevalence of Cost-Related Barriers to Health among Non-Elderly
Adults by ASCVD and Non-ASCVD/CRF Profile Status.
There was a stepwise increase in cost-related medication non-adherence, fore-
gone/delayed care, and high financial distress with worsening CRF profile.
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovas-
cular risk factor.
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reduction in financial hardship, we noted greater burden among those
who lacked health insurance and those with lower family income. In fact,
uninsured and lower income individuals with optimal CRF reported
similar burden of financial hardship such as an inability to pay medical
bills, CRN, foregone medical care, and financial distress as compared to
insured and middle/high incomes individuals with established ASCVD.
Our study results provide an impetus for health policy advocates and
other stakeholders on the benefits of an upfront investment in ASCVD
primordial and primary prevention. However, the significant risk of
financial hardship cannot be fully addressed without widening the scope
of insurance coverage and further limiting out-of-pocket expenditures for
the most vulnerable segments of our society. Further, it is critical to
carefully evaluate the complex, multidirectional interplay between
financial hardship, cardiovascular risk factors, and social determinants of
health. Considering the heightened risk of cardiovascular risk factors,
comorbidities, and adverse cardiac events and outcomes among in-
dividuals experiencing financial hardship from medical bills, it is
imperative to not only strive to improve CRF profiles in the general
population and particularly in low-resource settings, but also to
concurrently address the sociodemographic inequities themselves
through focused public health interventions and effective public policy
reform.
Developing and sustaining effective, patient-centered public health
interventions is critical for alleviating the burden and consequences of
cardiovascular risk factors in vulnerable and low-resource communities.
In recent years, community-based health workers (CBHW) have gained
attention for their ability promote healthy behaviors and positive out-
comes in underserved settings. Notably, a systematic review conducted
by Kim and colleagues found that the utilization of CMHW interventions
was associated with significant cardiovascular risk reduction and that the
roles of CMHW’s included health education, counseling, case manage-
ment, social services, and support [25]. Another review of the current
literature found that the most commonly implemented community-based
cardiovascular interventions included education followed by counseling
or support and exercise classes, with more than half of interventions
having multiple components [26]. Behavior change interventions were
found to be the most challenging to implement while programs devel-
oped to decrease blood pressure were the most effective. Future research
studies and public health interventions may derive benefit from inte-
grating components of the conceptual framework on patient centered
access to healthcare produced by Khanassov et al. describing core tenants
of improving healthcare access in low-resource settings such as
approachability, acceptability, availability, and affordability [27].
Our results should be interpreted given the following limitations. The
cross-sectional nature of our study precludes the establishment of causal
relationship between our studied outcomes and ASCVD or poor CRF
profile status. For example, poor cardiovascular health can predispose a
Fig. 4. Title: Prevalence of Cost-Related Barriers to Health by (A), family income (B), insurance status among Non-Elderly Adults by ASCVD and Non-ASCVD/CRF
Profile Status.
Within each CRF profile strata, individuals with lower income and lack of insurance had a higher prevalence of cost-related medication non-adherence, foregone/
delayed care, and high financial distress when compared with individuals with higher income and insurance coverage.
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovascular risk factor.
Table 4
Odds ratios of cost-related barriers to health among non-elderly adults by ASCVD
and non-ASCVD/CRF profile status.
ASCVD No ASCVD
Poor CRF
Profile
Average CRF
Profile
Optimal CRF
Profile
OR (95%
CI)
OR (95% CI) OR (95% CI) OR (95% CI)
Cost-Related Medication Non-Adherence
Model
1
Reference 0.86 (0.77,
0.97)
0.58 (0.52, 0.63) 0.32 (0.29, 0.36)
Model
2
0.91 (0.80,
1.03)
0.66 (0.59, 0.73) 0.42 (0.38, 0.48)
Foregone/Delayed care
Model
1
Reference 0.86 (0.78,
0.95)
0.53 (0.49, 0.57) 0.30 (0.27, 0.32)
Model
2
0.94 (0.84,
1.04)
0.63 (0.58, 0.69) 0.41 (0.37, 0.45)
High Financial Distress
Model
1
Reference 0.94 (0.85,
1.03)
0.65 (0.60, 0.71) 0.35 (0.32, 0.38)
Model
2
1.02 (0.91,
1.14)
0.79 (0.72, 0.87) 0.52 (0.47, 0.58)
Abbreviations: ASCVD, atherosclerotic cardiovascular disease; CRF, cardiovas-
cular risk factor; OR, odds ratios; CI, confidence interval.
Model 1: Unadjusted Model.
Model 2: adjusted for age, sex, race/ethnicity, geographic region, comorbidities,
family size, family income, education, and insurance status.
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family to overall financial hardship due to excessive out-of-pocket
healthcare costs, while similarly financial hardship from medical bills
may be a contributor to financial difficulties for any given individual or
family, predisposing to poor cardiovascular health. Therefore, a bilateral
causal relationship is plausible, and it is crucial to note that financial
hardship and poor cardiovascular health can cause and progressively
worsen each other with poor social determinants of health serving as the
root cause for either of them. This can be explained by the higher prev-
alence of ASCVD, poor CRF profile as well as financial hardship from
medical bills and other cost-related barriers to health among lower socio-
economic (lower education and income) and uninsured families in our
study. Second, since all the information regarding the study variables was
obtained through self-reported surveys, there is a potential for recall bias.
Therefore, underestimation of the true national prevalence of ASCVD and
modifiable risk factor status is likely, as described previously, especially
in chronic conditions [28]. Third, we were unable to calculate the ideal
CVH status as defined by American Heart Association due to lack of di-
etary information and clinical values of other relevant health factors.
In conclusion, we found that a favorable CRF profile is directly
associated with a significantly lower prevalence of financial hardship
from medical bills and other cost-related barriers to health, findings that
support nationwide policies focusing on preventing and managing
modifiable risk factors, irrespective of underlying CVD status.
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